Evidence map›Paper›PMID 31705128›Full record

ArticleScientific reports2019

Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population.

Nozomi Yokoyama, Aya Kawasaki, Takashi Matsushita, Hiroshi Furukawa, Yuya Kondo, Fumio Hirano, Ken-Ei Sada, Isao Matsumoto, Makio Kusaoi, Hirofumi Amano and 32 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genetic dissection ofRMD open · 2023
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 20 institutions in 1 country.

Nozomi YokoyamaUniversity of Tsukuba, Faculty of Medicine, Molecular and Genetic Epidemiology Laboratory, Tsukuba, Japan.
Aya KawasakiUniversity of Tsukuba, Faculty of Medicine, Molecular and Genetic Epidemiology Laboratory, Tsukuba, Japan. a-kawasaki@umin.net.
Takashi MatsushitaKanazawa University, Graduate School of Medical Sciences, Department of Dermatology, Kanazawa, Japan.ORCID http://orcid.org/0000-0002-1617-086X
Hiroshi FurukawaUniversity of Tsukuba, Faculty of Medicine, Molecular and Genetic Epidemiology Laboratory, Tsukuba, Japan.ORCID http://orcid.org/0000-0002-4022-0767
Yuya KondoUniversity of Tsukuba, Faculty of Medicine, Department of Internal Medicine, Tsukuba, Japan.
Fumio HiranoTokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Department of Rheumatology, Tokyo, Japan.ORCID http://orcid.org/0000-0002-5169-0692
Ken-Ei SadaOkayama University, Graduate School of Medicine, Density and Pharmaceutical Sciences, Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama, Japan.ORCID http://orcid.org/0000-0003-1020-0818
Isao MatsumotoUniversity of Tsukuba, Faculty of Medicine, Department of Internal Medicine, Tsukuba, Japan.
Makio KusaoiJuntendo University, School of Medicine, Department of Internal Medicine and Rheumatology, Tokyo, Japan.
Hirofumi AmanoJuntendo University, School of Medicine, Department of Internal Medicine and Rheumatology, Tokyo, Japan.
Shouhei NagaokaYokohama Minami Kyosai Hospital, Yokohama, Japan.
Keigo SetoguchiTokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Tatsuo NagaiKitasato University, Department of Rheumatology and Infectious Diseases, Sagamihara, Japan.
Kota ShimadaNational Hospital Organization Sagamihara National Hospital, Clinical Research Center for Allergy and Rheumatology, Sagamihara, Japan.
Shoji SugiiTokyo Metropolitan Tama Medical Center, Fuchu, Japan.ORCID http://orcid.org/0000-0001-6044-7187
Atsushi HashimotoNational Hospital Organization Sagamihara National Hospital, Clinical Research Center for Allergy and Rheumatology, Sagamihara, Japan.
Toshihiro MatsuiNational Hospital Organization Sagamihara National Hospital, Clinical Research Center for Allergy and Rheumatology, Sagamihara, Japan.
Akira OkamotoHimeji Medical Center, National Hospital Organization, Himeji, Japan.
Noriyuki ChibaMorioka Medical Center, National Hospital Organization, Morioka, Japan.
Eiichi SuematsuKyushu Medical Center, National Hospital Organization, Fukuoka, Japan.
Shigeru OhnoYokohama City University Medical Center, Yokohama, Japan.
Masao KatayamaNagoya Medical Center, National Hospital Organization, Nagoya, Japan.
Kiyoshi MigitaFukushima Medical University, School of Medicine, Fukushima, Japan.
Hajime KonoTeikyo University School of Medicine, Department of Internal Medicine, Tokyo, Japan.
Minoru HasegawaUniversity of Fukui, Department of Dermatology, Fukui, Japan.
Shigeto KobayashiJuntendo University Koshigaya Hospital, Koshigaya, Japan.
Hidehiro YamadaSt. Marianna University, School of Medicine, Department of Internal Medicine, Kawasaki, Japan.
Kenji NagasakaOme Municipal General Hospital, Ome, Japan.
Takahiko SugiharaTokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Department of Rheumatology, Tokyo, Japan.
Kunihiro YamagataUniversity of Tsukuba, Faculty of Medicine, Department of Nephrology, Tsukuba, Japan.ORCID http://orcid.org/0000-0002-7407-0410
Shoichi OzakiSt. Marianna University, School of Medicine, Department of Internal Medicine, Kawasaki, Japan.
Naoto TamuraJuntendo University, School of Medicine, Department of Internal Medicine and Rheumatology, Tokyo, Japan.
Yoshinari TakasakiJuntendo University, School of Medicine, Department of Internal Medicine and Rheumatology, Tokyo, Japan.
Hiroshi HashimotoJuntendo University School of Medicine, Tokyo, Japan.
Hirofumi MakinoOkayama University Hospital, Okayama, Japan.
Yoshihiro ArimuraKyorin University School of Medicine, First Department of Internal Medicine, Mitaka, Japan.
Masayoshi HarigaiDepartment of Rheumatology, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Shinichi SatoThe University of Tokyo, Department of Dermatology, Tokyo, Japan.
Takayuki SumidaUniversity of Tsukuba, Faculty of Medicine, Department of Internal Medicine, Tsukuba, Japan.
Shigeto TohmaNational Hospital Organization Sagamihara National Hospital, Clinical Research Center for Allergy and Rheumatology, Sagamihara, Japan.
Kazuhiko TakeharaKanazawa University, Graduate School of Medical Sciences, Department of Dermatology, Kanazawa, Japan.
Naoyuki TsuchiyaUniversity of Tsukuba, Faculty of Medicine, Molecular and Genetic Epidemiology Laboratory, Tsukuba, Japan. tsuchiya-tky@umin.net.ORCID http://orcid.org/0000-0002-6776-5580
University of Tsukuba · JPJuntendo University · JPNational Sagamihara Hospital · JPKanazawa University · JPNational Hospital Organization · JPSt. Marianna University School of Medicine · JPTokyo Medical and Dental University · JPDokkyo Medical University Saitama Medical Center · JPFukushima Medical University · JPHimeji Medical Center · JPKitasato University · JPKyorin University · JPNational Kyushu Medical Center · JPOkayama University · JPOkayama University Hospital · JPOme Municipal General Hospital · JPTeikyo University · JPThe University of Tokyo · JPTokyo Metropolitan Komagome Hospital · JPTokyo Metropolitan Tama Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide association studies of systemic lupus erythematosus (SLE) in Chinese and Korean populations demonstrated strong association of single nucleotide polymorphisms (SNPs) located in the GTF2I-NCF1 region, rs73366469 (GTF2I), rs117026326 (GTF2I), rs80346167(GTF2IRD1) and rs201802880 (NCF1). This region has also been associated with susceptibility to Sjögren syndrome and rheumatoid arthritis; however, association studies with systemic sclerosis (SSc) and ANCA-associated vasculitis (AAV) have not been reported. Here we made an attempt to confirm their associations with SLE in the Japanese population, to find the primarily associated SNP, and to investigate whether these SNPs are also associated with susceptibility to SSc and AAV. By genotyping these four SNPs on 842 SLE, 467 SSc, 477 AAV patients and 934 healthy controls, striking association was confirmed in Japanese SLE. In addition, these SNPs were significantly associated with susceptibility to SSc, but not with AAV. Conditional logistic regression analysis revealed that the association of NCF1 rs201802880, a missense SNP encoding p.Arg90His, can account for the association of other SNPs by linkage disequilibrium. These results suggested that GTF2I-NCF1 region is associated with susceptibility to multiple autoimmune rheumatic diseases but not with AAV, and the primarily associated variant may be the missense SNP in NCF1.

Indexed as

Polymorphism, Single NucleotideAdultAge of OnsetAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAsian PeopleCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansJapanLinkage DisequilibriumLupus Erythematosus, SystemicMaleNADPH OxidasesPrevalenceNADPH Oxidasesneutrophil cytosolic factor 1

Identifiers

PMID31705128
PMCPMC6842004
OpenAlexW2984849720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.